131
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Factorial Design in the Optimization and Study ‘in combo’ of Derivatives of imidazo[1,2-a]azines in the COX´s Isoforms Inhibition

ORCID Icon, ORCID Icon & ORCID Icon
Pages 771-784 | Received 24 Jan 2022, Accepted 25 Mar 2022, Published online: 10 May 2022

References

  • Medzhitov R . Origin and physiological roles of inflammation. Nature454(7203), 428–435 (2008).
  • Medzhitov R . Inflammation 2010: new adventures of an old flame. Cell140(6), 771–776 (2010).
  • Williams C , DuBoisR. Prostaglandin endoperoxide synthase: why two isoforms?Am. J. Physiol. Gastrointest. Liver Physiol.270(3), G393–G400 (1996).
  • Fitzpatrick FA . Cyclooxygenase enzymes: regulation and function. Curr. Pharm. Des.10(6), 577–588 (2004).
  • Lacerda RB , de LimaCKF , da SilvaLLet al. Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes. Bioorg. Med. Chem.17(1), 74–84 (2009).
  • Márquez-Flores YK , Campos-AldreteME , Salgado-ZamoraH , Correa-BasurtoJ , Meléndez-CamargoME. Acute and chronic anti-inflammatory evaluation of imidazo[1,2-a]pyridine carboxylic acid derivatives and docking analysis. Med. Chem. Res.21(11), 3491–3498 (2012).
  • Márquez-Flores YK , Campos-AldreteME , Salgado-ZamoraH , Correa-BasurtoJ , Meléndez-CamargoME. Docking simulations, synthesis, and anti-inflammatory activity evaluation of 2-(N-alkyl)amino-3-nitroimidazo[1,2-a]pyridines. Med. Chem. Res.21(6), 775–782 (2012).
  • Martins Fukuda I , FidelisPinto CF , dosSantos Moreira C , MoraisSaviano A , RebelloLourenço F. Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD). Braz. J. Pharm. Sci.54(Special), e01006 (2018).
  • João Ramalho M , LoureiroAJ , CoelhoANM , CarmoPereira M. Factorial design as a tool for the optimization of PLGA nanoparticles for the co-delivery of temozolomide and o6-benzylguanine. Pharmaceutics11(8), 401 (2019).
  • Akar Sen G . Application of full factorial experimental design and response surface methodology for chromite beneficiation by Knelson concentrator. Minerals6(1), 5 (2016).
  • Bagdi AK , SantraS , MonirK , HajraA. Synthesis of imidazo[1,2-a]pyridines: a decade update. Chem. Commun.51(9), 1555–1575 (2015).
  • Sundberg RJ , DahlhausenDJ , ManikumarGet al. Preparation of 2-aryl and 2-aryloxymethyl imidazo[1,2-a]pyridines and related compounds. J. Heterocycl. Chem.25(1), 129–137 (1988).
  • Dylong A , SowaM , GoldemanWet al. Imidazo[1,2-a]pyridin-2-ylacetic acid and two pairs of isomorphous ML2(H2O)2 dihydrates (M = Ni, Co and Mn, Cd) based on its anion: syntheses, crystal structures and properties. Polyhedron75, 9–21 (2014).
  • Dylong A , GoldemanW , SowaM , ŚlepokuraK , DrozdzewskiP , Matczak-JonE. Synthesis, crystal structures and spectral characterization of imidazo[1,2-a]pyrimidin-2-yl-acetic acid and related analog with imidazo[2,1-b]thiazole ring. J. Mol. Struc.1117, 153–163 (2016).
  • Awang Hamsin DEZ , AbdulHamid R , SaifulYazan L , MatTaib CN , YeongLT. Ardisia crispa roots inhibit cyclooxygenase and suppress angiogenesis. BMC Complement. Altern. Med.14(1), 102 (2014).
  • Almansa C , DeArriba AF , CavalcantiFLet al. Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-α]pyrimidines. J. Med. Chem.44(33), 350–361 (2001).
  • Simmons DL , BottingRM , HlaT. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev.56(3), 387–437 (2004).
  • Baek SH , HwangS , ParkT , KwonYJ , ChoM , ParkD. Evaluation of selective COX-2 inhibition and in silico study of Kuwanon derivatives isolated from Morus alba. Int. J. Mol. Sci.22(7), 3659 (2021).
  • Rao PNP , KnausEE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J. Pharm. Pharm. Sci11(2), 81–110S (1997).
  • Shrivastava SK , SrivastavaP , BandreshR , TripathiPN , TripathiA. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity. Bioorg. Med. Chem.25, 4424–4432 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.